Alimjon Matchanov | Pharmacology| Human-AI Integration Award

Human-AI Integration Award

Alimjon Matchanov
Institute of Bioorganic Chemistry

Alimjon Matchanov
Affiliation Institute of Bioorganic Chemistry
Country Uzbekistan
Scopus ID 57216340726
Documents 42
Citations 167
h-index 8
Subject Area Pharmacology
Event International Cognitive Scientist Awards
ORCID 0000-0002-4176-3990

Alimjon Matchanov is a researcher affiliated with the Institute of Bioorganic Chemistry in Uzbekistan, working in pharmacology. His academic publication record reflects research activity in bioorganic chemistry and related pharmaceutical sciences. His profile is presented in connection with the Human-AI Integration Award under the International Cognitive Scientist Awards.

Abstract

This academic profile highlights Alimjon Matchanov’s research background in pharmacology and bioorganic chemistry. With 42 indexed documents, 167 citations and an h-index of 8, his Scopus profile provides indicators of scholarly activity. The Human-AI Integration Award recognizes the importance of interdisciplinary research and the potential integration of artificial intelligence into scientific investigation. [1]

Keywords

Pharmacology, Bioorganic Chemistry, Drug Research, Biological Activity, Pharmaceutical Sciences, Artificial Intelligence, Human-AI Integration, Interdisciplinary Research and Scientific Innovation.

Introduction

Artificial intelligence is creating new opportunities in scientific research through computational modelling, data analysis and interdisciplinary collaboration. In pharmacology and bioorganic chemistry, these technologies can support molecular investigation and biological data interpretation. This provides an important context for examining connections between pharmaceutical sciences and emerging technologies.

Research Profile

Alimjon Matchanov is associated with the Institute of Bioorganic Chemistry, Uzbekistan. His research subject area is pharmacology, which investigates drug action, biological responses and therapeutic substances. His supplied Scopus profile records 42 documents, 167 citations and an h-index of 8. [1]

Research Contributions

Pharmacology and bioorganic chemistry contribute to understanding biologically active compounds and their potential applications. Relevant interdisciplinary research directions include:

  • Computational approaches to pharmaceutical research.
  • Investigation of biological activity.
  • Integration of computational tools with bioorganic chemistry.
  • Interdisciplinary scientific collaboration.

Publications

The researcher’s Scopus profile records 42 scholarly documents. These publications provide a basis for examining his academic research activity. Individual publication titles, journal details and DOI identifiers should be verified against the original bibliographic records before inclusion. [1]

Research Impact

The supplied Scopus indicators report 167 citations and an h-index of 8. These metrics provide quantitative information about publication visibility and citation activity. They should be considered alongside research quality, originality, scientific relevance and verified contributions. [1]

Award Suitability

The Human-AI Integration Award recognizes research connecting artificial intelligence with scientific disciplines and practical applications. Matchanov’s pharmacology and bioorganic chemistry background provides an interdisciplinary scientific context. However, the supplied bibliometric information alone does not establish direct AI research contributions. Award suitability should be assessed through verified AI-related publications, research methods, collaborative projects or demonstrated applications of artificial intelligence.

Conclusion

Alimjon Matchanov’s academic profile demonstrates research activity in pharmacology and bioorganic chemistry, supported by the supplied Scopus indicators. His profile provides an opportunity to examine interdisciplinary connections between pharmaceutical sciences and emerging computational technologies. Further evidence of documented AI integration would strengthen the assessment of his suitability for the Human-AI Integration Award.

References

  1. Elsevier. (n.d.). Scopus author details: Alimjon Matchanov, Author ID 57216340726. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57216340726
  2. ORCID. (n.d.). Alimjon Matchanov: ORCID researcher record.
    https://orcid.org/0000-0002-4176-3990
  3. International Cognitive Scientist Awards. (n.d.). Awards and recognition platform.
    https://cognitivescientist.org/

 

Muhammad Afzal | Pharmacology | Excellence in Research

Prof. Muhammad Afzal | Pharmacology | Excellence in Research   🏆

Professor at Batterjee Medical College, Saudi Arabia

Prof. Muhammad Afzal is a distinguished academic and researcher specializing in drug discovery and development, anticancer drug discoveries, neuropharmacology, and endocrinology. He holds a Ph.D. in Pharmacology from Pacific Academy of Higher Education and Research University, Udaipur, and has extensive experience in pharmacology and pharmaceutical sciences. Currently, he serves as a Professor and Research Coordinator at Batterjee Medical College, Jeddah, Saudi Arabia. Prof. Afzal has contributed significantly to scientific research, with expertise in various animal models and advanced analytical techniques. His work has earned him notable recognition, including a Research Excellence Award from Jouf University, Saudi Arabia, and selection for Post-Doctoral Research at the Institute of Post Graduate Studies, Malaysia. Prof. Afzal’s innovative research, particularly in the fields of neuropharmacology and endocrine disorders, continues to have a profound impact on both academics and the broader scientific community.

Profile

SCOPUS

GOOGLE SCHOLAR

ORCID

Education 🎓:

Prof. Muhammad Afzal completed his Ph.D. in Pharmacology from Pacific Academy of Higher Education and Research University, Udaipur, in 2014. Prior to that, he earned his M. Pharm in Pharmacology from S.K. Patel College of Pharmaceutical Education & Research, Ganpat University, Mehsana, in 2009. He also holds a B. Pharm degree from HNB Garhwal University, Shrinagar, Uttarakhand, awarded in 2007. Additionally, Prof. Afzal is a registered pharmacist with the Uttar Pradesh Pharmacy Council (Reg. No. 50848). His academic journey reflects a solid foundation in pharmacology, supported by his successful completion of the IELTS (International English Language Testing System) with an overall score of 6 bands, which he undertook at the IDP Centre, Aljouf University, Sakaka, Saudi Arabia, in December 2021. This diverse educational background highlights Prof. Afzal’s comprehensive expertise in pharmaceutical sciences and his commitment to continuous learning and professional development.

Work Experience 💼:

Prof. Muhammad Afzal has extensive academic and research experience in the field of pharmacology and pharmaceutical sciences. He currently serves as a Professor and Research Coordinator at the Department of Pharmaceutical Sciences, Batterjee Medical College, Jeddah, Saudi Arabia, where he contributes to both teaching and research activities. Prior to this, he worked as a Professor at the Department of Pharmacology, Himalayan Institute of Pharmacy and Research, Dehradun, where he delivered lectures on Physiology, Pathophysiology, Anatomy, and Pharmacology to postgraduate and undergraduate pharmacy students. Prof. Afzal’s professional journey also includes significant research involvement, where he has led numerous studies on drug discovery, anticancer drug development, and neuropharmacology. His research expertise extends to animal models, analytical techniques, and the establishment of the mechanism of action of drugs, making him a valuable contributor to advancing the field of pharmacological research.

Skills 🔍

Prof. Muhammad Afzal possesses a diverse set of research and technical skills that span across various domains of pharmacology and drug discovery. He is highly proficient in the use of advanced analytical instruments, such as UV spectrophotometers, semi-auto analyzers, fully automated hematology analyzers, RT-PCR, ELISA readers, and western blot analyzers. His expertise extends to the mechanism of drug action, where he has successfully established drug interactions using various experimental animal models. Prof. Afzal is also skilled in animal handling, working with species such as rats, mice, guinea pigs, and rabbits, and is well-versed in administering drugs through different routes. Furthermore, his technical competence includes the use of Langendorff’s assembly for cardiac studies and various biological assays for testing drug efficacy, such as those related to asthma, diabetes, inflammatory bowel disease, cancer, and cardiovascular diseases. His ability to utilize state-of-the-art research techniques and conduct preclinical studies has made him a valuable asset in the pharmaceutical research community.

Research Interests:

Prof. Muhammad Afzal’s primary research interests lie in the fields of drug discovery and development, with a particular focus on anticancer drug discoveries, neuropharmacology, and endocrinology. He is dedicated to exploring innovative approaches in pharmacology, particularly in the development of novel therapies for cancer, neurological disorders, and endocrine-related diseases. Prof. Afzal is also deeply involved in studying the mechanisms of drug action using various animal models for diseases like diabetes, hypertension, asthma, anti-inflammatory disorders, and cardiovascular diseases. His work integrates both in vivo and computational techniques to investigate the biochemical, histopathological, and molecular interactions of therapeutic agents. Additionally, Prof. Afzal’s research focuses on understanding the pathophysiological processes underlying neurodegenerative diseases such as Huntington’s disease and diabetes, with the aim of developing targeted treatments for these complex conditions.

📚 Publications 

  • Title: Ectopic Pregnancy: A Review
    • Authors: P Rana, I Kazmi, R Singh, M Afzal, FA Al-Abbasi, A Aseeri, R Singh et al.
    • Journal: Archives of Gynecology and Obstetrics
    • Year: 2013
    • Citations: 233
  • Title: Sedative, Antiepileptic, and Antipsychotic Effects of Viscum album L. (Loranthaceae) in Mice and Rats
    • Authors: G Gupta, I Kazmi, M Afzal, M Rahman, S Saleem, MS Ashraf, MJ Khusroo et al.
    • Journal: Journal of Ethnopharmacology
    • Year: 2012
    • Citations: 176
  • Title: Classical to Current Approach for Treatment of Psoriasis: A Review
    • Authors: M Rahman, K Alam, M Zaki Ahmad, G Gupta, M Afzal, S Akhter, I Kazmi et al.
    • Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
    • Year: 2012
    • Citations: 158
  • Title: Anti-inflammatory and Analgesic Potential of a Novel Steroidal Derivative from Bryophyllum pinnatum
    • Authors: M Afzal, G Gupta, I Kazmi, M Rahman, O Afzal, J Alam, KR Hakeem et al.
    • Journal: Fitoterapia
    • Year: 2012
    • Citations: 127
  • Title: Advancement in Multifunctional Nanoparticles for the Effective Treatment of Cancer
    • Authors: M Rahman, MZ Ahmad, I Kazmi, S Akhter, M Afzal, G Gupta et al.
    • Journal: Expert Opinion on Drug Delivery
    • Year: 2012
    • Citations: 127

Conclusion 

Prof. Muhammad Afzal’s outstanding research in drug discovery, neuropharmacology, and endocrinology, his leadership in academic settings, and his international recognition make him an exemplary candidate for the Research for Excellence in Research award. His ability to conduct groundbreaking research while mentoring future scientists positions him as a true leader in his field.

Ruzanna Paronikyan | pharmacology | Best Researcher Award

Assoc Prof Dr. Ruzanna Paronikyan | pharmacology | Best Researcher Award 🏆

pharmacologist at Scientific and Technological Center of Organic and Pharmaceutical Chemistry NAS of Armenia🎓

🌟 Ruzanna Paronikyan is a highly accomplished Doctor of Biological Sciences with a specialization in pharmacology and physiology. She completed her education at Yerevan State University in the Faculty of Biology, where she spent five years earning her diploma as a biologist and biology and chemistry teacher.

Professional Profile 

🎓 Education

Ruzanna earned her Ph.D. in 1990, specializing in pharmacology, and later, in 2021, she was awarded a Doctor of Biological Sciences degree with a focus on the physiology of humans and animals. Over the years, she has published numerous research articles in renowned journals on neurotropic drugs, anticonvulsants, and biological activity synthesis.

🏢 Work Experience

💼 Ruzanna works at the National Academy of Sciences of the Republic of Armenia, specifically in the Laboratory of Pharmacology and Histopathology, where she serves as a Leading Researcher. Her focus is on pharmacological research, particularly the synthesis and biological activities of compounds with potential anticonvulsant and psychotropic properties. She has led several significant research grants, including thematic funding from the State Committee of Science for projects from 2013-2015 and 2021-2024.

🧬 Skills

Ruzanna is skilled in experimental pharmacology, histopathology, and chemistry, particularly in synthesizing bioactive compounds. She holds the prestigious title of Academician of the Russian Academy of Natural Sciences and is a certified docent.

🌍 Memberships

Along with her academic titles, she is an active member of the Russian Academy of Natural Sciences and has contributed extensively to advancing pharmacological research in Armenia and internationally.

📚 Teaching Experience

📚 While most of her career has been in research, Ruzanna’s foundation in biology and chemistry education and her status as a certified docent indicate her involvement in teaching and mentoring young scientists, particularly in the fields of biological sciences and pharmacology.

🔬 Research Focus

🔬Her research primarily centers around the synthesis of neurotropic and anticonvulsant compounds, with a strong interest in their pharmacological properties. She has collaborated on various studies exploring how synthesized compounds affect neurological conditions, including epilepsy and other psychotropic disorders.

 

📚 Publilcation 

Title: Synthesis and Evaluation of the Neurotropic Activity of New β-Cycloketol Derivatives
Authors: Kocharov, S.L., Panosyan, H.A., Mirzoyan, L.S., Nazaryan, I.M., Paronikyan, R.G.
Journal: Pharmaceutical Chemistry Journal
Year: 2024
Citations: 0

Title: Synthesis and Psychotropic Properties of Novel Condensed Triazines for Drug Discovery
Authors: Paronikyan, E.G., Dashyan, S.S., Mamyan, S.S., Hunanyan, L.S., Hobosyan, N.G.
Journal: Pharmaceuticals
Year: 2024
Citations: 0

Title: Synthesis, Evaluation of Biological Activity and SAR of New Thioalkyl Derivatives of Pyridine
Authors: Dashyan, S., Babaev, E.V., Ayvazyan, A.G., Hunanyan, L.S., Paronikyan, R.G.
Journal: Bioorganic Chemistry
Year: 2024
Citations: 0

Title: Synthesis and Neurotropic Activity of New Derivatives of Some Amino Acid Hydantoins and Their Lithium Salts
Authors: Paronikyan, R.G., Grigoryan, A.S., Barkhudaryants, I.M., Arshakyan, L.M., Harutyunyan, A.A.
Journal: Bioactive Compounds in Health and Disease
Year: 2024
Citations: 0

Title: Synthesis and Evaluation of the Biological Activity of New Succinimides Substituted at the Nitrogen Atom with Benzenesulfonamides
Authors: Kocharov, S.L., Panosyan, H.A., Jaghatspanyan, I.A., Stepanyan, H.M., Paronikyan, R.V.
Journal: Pharmaceutical Chemistry Journal
Year: 2023
Citations: 0

Title: New Bicyclic Pyridine-Based Hybrids Linked to the 1,2,3-Triazole Unit: Synthesis via Click Reaction and Evaluation of Neurotropic Activity and Molecular Docking
Authors: Sirakanyan, S.N., Spinelli, D., Petrou, A., Arakelyan, T.A., Hovakimyan, A.A.
Journal: Molecules
Year: 2023
Citations: 2

Title: Assessing Neurotropic Effects of New Antiepileptic Nitrogen-Containing Drugs
Authors: Paronikyan, R.G., Avakyan, G.G., Avakyan, V.N., Paronikyan, E.G.
Journal: Epilepsy and Paroxysmal Conditions
Year: 2023
Citations: 1

Title: Evaluation of Neurotropic Activity and Molecular Docking Study of New Derivatives of pyrano[4″,3″:4′,5′]pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidines
Authors: Dashyan, S.Sh., Babaev, E., Paronikyan, E., Paronikyan, R., Hunanyan, L.
Journal: Molecules
Year: 2022
Citations: 2

Title: Synthesis, Neurotropic Activity, and Molecular Docking of New Condensed Thieno[2,3-b]pyridine Derivatives
Authors: Dabaeva, V.V., Baghdasaryan, M.R., Paronikyan, R.G., Paronikyan, E.G., Dashyan, S.S.
Journal: Russian Journal of Bioorganic Chemistry
Year: 2022
Citations: 2